{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:52Z","timestamp":1791639592759,"version":"4.3.4"},"reference-count":54,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Focal therapy for prostate cancer (PCa) provides approaches to treat PCa patients in a less invasive manner than traditional whole-gland surgical or radiation modalities. This manuscript provides a case series of high-intensity focused ultrasound (HIFU), cryoablation, and irreversible electroporation (IRE) for PCa at a single institution and cost analysis with a review of the literature. All patients who underwent HIFU, cryoablation, or IRE for localized PCa were retrospectively reviewed, excluding patients who received whole-gland therapy. Functional outcomes were erectile dysfunction and lower urinary tract symptoms. Cost data were collected. A total of 45 patients were included in the study with focal therapy ranging from 2023 to 2025 (4 HIFU, 20 cryoablation, 21 IRE). A total of 30 patients had focally treated lesions, and 15 patients had hemi-gland treatment. The mean preoperative PSA was 7.7 ng\/mL. On the paired sample t-test, there was no significant difference between pre-focal and post-focal therapy PSA. Three patients experienced biochemical recurrence requiring prostate biopsy after focal treatment. Mean cost was USD 3804.50 and not significantly different by focal treatment. No metastatic events occurred nor deaths at a median follow-up of 6 months.\u00a0Patients in this series had largely unaltered functional outcomes. Cost analysis in contemporary publications is lacking. Although follow-up was short, cancer control was adequate.<\/jats:p>","DOI":"10.3390\/curroncol32090476","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:09:53Z","timestamp":1756080593000},"page":"476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Focal Therapy for Localized Prostate Cancer: A Case Series with Cost Analysis"],"prefix":"10.3390","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2880-1857","authenticated-orcid":false,"given":"Maxwell","family":"Sandberg","sequence":"first","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"},{"name":"Comprehensive Cancer Center, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4404-0606","authenticated-orcid":false,"given":"David","family":"Thole","sequence":"additional","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Nowatzke","sequence":"additional","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Underwood","sequence":"additional","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9466-9925","authenticated-orcid":false,"given":"Soroush","family":"Rais-Bahrami","sequence":"additional","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"},{"name":"Comprehensive Cancer Center, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"},{"name":"Comprehensive Cancer Center, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA"},{"name":"Comprehensive Cancer Center, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC 27101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"ref_1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1464-410X.2010.09833.x","article-title":"Early prostate cancer\u2014Which treatment do men prefer and why?","volume":"107","author":"Anandadas","year":"2011","journal-title":"BJU Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1002\/cam4.3482","article-title":"Trends in prostatectomy utilization: Increasing upfront prostatectomy and postprostatectomy radiotherapy for high-risk prostate cancer","volume":"9","author":"Kaps","year":"2020","journal-title":"Cancer Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2429760","DOI":"10.1001\/jamanetworkopen.2024.29760","article-title":"Trends in Active Surveillance for Men with Intermediate-Risk Prostate Cancer","volume":"7","author":"Diven","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.urolonc.2016.01.008","article-title":"The effect of minimally invasive prostatectomy on practice patterns of American urologists","volume":"34","author":"Oberlin","year":"2016","journal-title":"Urol. Oncol."},{"key":"ref_6","unstructured":"Lee, D., Tan, H.-J., Fang, R., Mbassa, R., and Matulewicz, R. (2025, June 19). Primary Question: How Has the Average Number of Radical Prostatectomies Performed by Urologists Changed Over Time?, AUA NEWS, Available online: https:\/\/auanews.net\/issues\/articles\/2023\/october-extra-2023\/primary-question-how-has-the-average-number-of-radical-prostatectomies-performed-by-urologists-changed-over-time."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104.e1","DOI":"10.1016\/j.urolonc.2022.07.014","article-title":"Functional outcomes after prostate cancer treatment: A comparison between single and multiple modalities","volume":"41","author":"Muise","year":"2023","journal-title":"Urol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2010.1720","article-title":"Active surveillance compared with initial treatment for men with low-risk prostate cancer: A decision analysis","volume":"304","author":"Hayes","year":"2010","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e231439","DOI":"10.1001\/jamanetworkopen.2023.1439","article-title":"Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US","volume":"6","author":"Cooperberg","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e00027","DOI":"10.1097\/JU9.0000000000000131","article-title":"Long-Term Trends in Decisional Regret Among Men with Localized Prostate Cancer","volume":"2","author":"Spellman","year":"2024","journal-title":"JU Open Plus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaoncol.2021.5160","article-title":"Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer","volume":"8","author":"Wallis","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_13","unstructured":"Leslie, S., Soon-Sutton, W., and Skelton, W. (2024). Prostate Cancer. StatPearls, StatPearls Publishing."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"241.e7","DOI":"10.1016\/j.urolonc.2018.02.003","article-title":"Prostate cancer management choices in patients undergoing multiparametric magnetic resonance imaging\/ultrasound fusion biopsy compared to systematic biopsy","volume":"36","author":"Gordetsky","year":"2018","journal-title":"Urol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.urology.2018.08.027","article-title":"How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?","volume":"122","author":"Dix","year":"2018","journal-title":"Urology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.humpath.2018.03.005","article-title":"Defining the optimal method for reporting prostate cancer grade and tumor extent on magnetic resonance\/ultrasound fusion-targeted biopsies","volume":"76","author":"Gordetsky","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5152\/dir.2014.14134","article-title":"Image-guided focal therapy for prostate cancer","volume":"20","author":"Sankineni","year":"2014","journal-title":"Diagn. Interv. Radiol. Ank. Turk."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2023.06.013","article-title":"Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement","volume":"84","author":"Deivasigamani","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"712.e1","DOI":"10.1016\/j.clgc.2023.04.013","article-title":"An Update on Focal Therapy for Prostate Cancer","volume":"21","year":"2023","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","article-title":"A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Guenther, E., Klein, N., Zapf, S., Weil, S., Schlosser, C., Rubinsky, B., and Stehling, M.K. (2019). Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0215093"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: Five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management","volume":"208","author":"Eastham","year":"2022","journal-title":"J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.21037\/tau-20-1212","article-title":"Focal therapy for primary and salvage prostate cancer treatment: A narrative review","volume":"10","author":"Tracey","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jvir.2019.07.001","article-title":"Focal Salvage MR Imaging-Guided Cryoablation for Localized Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up","volume":"31","author":"Bomers","year":"2020","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bju.13831","article-title":"Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer","volume":"120","author":"Kanthabalan","year":"2017","journal-title":"BJU Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41391-023-00702-1","article-title":"The state of focal therapy in the treatment of prostate cancer: The university of California collaborative (UC-Squared) consensus statement","volume":"27","author":"Brisbane","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bju.15883","article-title":"Guidelines of guidelines: Focal therapy for prostate cancer, is it time for consensus?","volume":"131","author":"Ong","year":"2023","journal-title":"BJU Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bju.16360","article-title":"The FocAL therapy CONsensus (FALCON): Enhancing partial gland ablation for localised prostate cancer","volume":"134","author":"Reiter","year":"2024","journal-title":"BJU Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/bju.16669","article-title":"Refining partial gland ablation for localised prostate cancer: The FALCON project","volume":"135","author":"Cathelineau","year":"2025","journal-title":"BJU Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00345-016-1932-1","article-title":"Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: Report from a Delphi consensus project","volume":"35","author":"Scheltema","year":"2017","journal-title":"World J. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.urology.2017.02.027","article-title":"Pathological Findings in Multiparametric Magnetic Resonance Imaging\/Ultrasound Fusion-guided Biopsy: Relation to Prostate Cancer Focal Therapy","volume":"105","author":"Gordetsky","year":"2017","journal-title":"Urology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00345-022-04024-0","article-title":"Alternative- and focal therapy trends for prostate cancer: A total population analysis of in-patient treatments in Germany from 2006 to 2019","volume":"40","author":"Flegar","year":"2022","journal-title":"World J. Urol."},{"key":"ref_36","first-page":"155","article-title":"Focal Therapy of prostate cancer: Energies and procedures","volume":"31","author":"Bozzini","year":"2013","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"584784","DOI":"10.1155\/2011\/584784","article-title":"Pros and cons of focal therapy for localised prostate cancer","volume":"2011","author":"Mearini","year":"2011","journal-title":"Prostate Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Tay, K.J., Fong, K.Y., Stabile, A., Dominguez-Escrig, J.L., Ukimura, O., Rodriguez-Sanchez, L., Blana, A., Becher, E., and Laguna, M.P. (2024). Established focal therapy-HIFU, IRE, or cryotherapy-where are we now?\u2014A systematic review and meta-analysis. Prostate Cancer Prostatic Dis.","DOI":"10.1038\/s41391-024-00911-2"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/pcan.2015.55","article-title":"A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer","volume":"19","author":"Aoun","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.purol.2018.07.285","article-title":"[Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year]","volume":"28","author":"Arnouil","year":"2018","journal-title":"Prog. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/JU.0000000000001015","article-title":"Prospective Evaluation of Focal High Intensity Focused Ultrasound for Localized Prostate Cancer","volume":"204","author":"Nahar","year":"2020","journal-title":"J. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1089\/end.2014.0881","article-title":"Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population","volume":"29","author":"Mendez","year":"2015","journal-title":"J. Endourol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/pros.24517","article-title":"Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored study","volume":"83","author":"Tan","year":"2023","journal-title":"Prostate"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1097\/01.JU.0001008692.26556.39.16","article-title":"MP25-16 FOCAL CRYOTHERAPY FOR LOCALIZED PROSTATE CANCER: INITIAL REPORT FROM THE INTERNATIONAL FOCAL THERAPY SOCIETY (FTS) REGISTRY","volume":"211","author":"Rastinehad","year":"2024","journal-title":"J. Urol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12672-025-02025-0","article-title":"A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer","volume":"16","author":"Xia","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"\u015alusarczyk, A., Gurwin, A., Barna\u015b, A., Ismail, H., Miszczyk, M., Zapa\u0142a, P., Przydacz, M., Krajewski, W., Antczak, A., and \u017byczkowski, M. (2025). Outcomes of Focal Therapy for Localized Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Eur. Urol. Oncol., S2588931125000392.","DOI":"10.1016\/j.euo.2025.02.003"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euo.2021.08.001","article-title":"Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard","volume":"5","author":"Stabile","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.eururo.2012.05.044","article-title":"Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy","volume":"62","author":"Novara","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(16)30661-1","article-title":"Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): An open-label, phase 3, randomised controlled trial","volume":"18","author":"Azzouzi","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2018.05.121","article-title":"PCM301 Study Group Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness","volume":"200","author":"Gill","year":"2018","journal-title":"J. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/JU.0000000000002972","article-title":"Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer Treatment","volume":"209","author":"Labbate","year":"2023","journal-title":"J. Urol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/13696998.2023.2251849","article-title":"Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: Results of a cost-effectiveness analysis","volume":"26","author":"Reddy","year":"2023","journal-title":"J. Med. Econ."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e20230132","DOI":"10.1590\/1980-220x-reeusp-2023-0132en","article-title":"Direct costs of treating men with prostate cancer with High Intensity Focused Ultrasound","volume":"57","author":"Lima","year":"2023","journal-title":"Rev. Esc. Enferm. USP"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/9\/476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:34:34Z","timestamp":1760034874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/9\/476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["curroncol32090476"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32090476","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]}}}